Raymond H Chan,Laurine van der Wal,Gabriela Liberato,Ethan Rowin,Jonathan Soslow,Shiraz Maskatia,Sherwin Chan,Amee Shah,Mark Fogel,Lazaro Hernandez,Shafkat Anwar,Inga Voges,Marcus Carlsson,Sujatha Buddhe,Kai Thorsten Laser,Gerald Greil,Emanuela Valsangiacomo-Buechel,Iacopo Olivotto,Derek Wong,Cordula Wolf,Heynric Grotenhuis,Carsten Rickers,Kan Hor,Tobias Rutz,Shelby Kutty,Margaret Samyn,Tiffanie Johnson,Keren Hasbani,Jeremy P Moore,Ludger Sieverding,Jon Detterich,Rodrigo Parra,Paweena Chungsomprasong,Olga Toro-Salazar,Arno A W Roest,Sven Dittrich,Henrik Brun,Joseph Spinner,Wyman Lai,Adrian Dyer,Robert Jablonowsk,Christian Meierhofer,Dominik Gabbert,Milan Prsa,Jyoti Kandlikar Patel,Andreas Hornung,Simone Goa Diab,Aswathy Vaikom House,Harry Rakowski,Lee Benson,Martin S Maron,Lars Grosse-Wortmann

Abstract:Importance: The ability to predict sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM) is currently inadequate. Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) imaging is associated with SCD events in adults with HCM. Objective: To examine the prognostic significance of LGE in patients with HCM who are younger than 21 years. Design, setting, and participants: This multicenter, retrospective cohort study was conducted from April 8, 2015, to September 12, 2022, in patients with HCM who were younger than 21 years and had undergone CMR imaging across multiple sites in the US, Europe, and South America. Observers of CMR studies were masked toward outcomes and demographic characteristics. Exposure: Natural history of HCM. Main outcome and measures: The primary outcome was SCD and surrogate events, including resuscitated cardiac arrest and appropriate discharges from an implantable defibrillator. Continuous and categorical data are expressed as mean (SD), median (IQR), or number (percentage), respectively. Survivor curves comparing patients with and without LGE were constructed by the Kaplan-Meier method, and likelihood of subsequent clinical events was further evaluated using univariate and multivariable Cox proportional hazards models. Results: Among 700 patients from 37 international centers, median (IQR) age was 14.8 (11.9-17.4) years, and 518 participants (74.0%) were male. During a median (IQR) [range] follow-up period of 1.9 (0.5-4.1) [0.1-14.8] years, 35 patients (5.0%) experienced SCD or equivalent events. LGE was present in 230 patients (32.9%), which constituted an mean (SD) burden of 5.9% (7.3%) of left ventricular myocardium. The LGE amount was higher in older patients and those with greater left ventricular mass and maximal wall thickness; patients with LGE had lower left ventricular ejection fractions and larger left atrial diameters. The presence and burden of LGE was associated with SCD, even after correcting for existing risk stratification tools. Patients with 10% or more LGE, relative to total myocardium, had a higher risk of SCD (unadjusted hazard ratio [HR], 2.19; 95% CI, 1.59-3.02; P < .001). Furthermore, the addition of LGE burden improved the performance of the HCM Risk-Kids score (before LGE addition: 0.66; 95% CI, 0.58-0.75; after LGE addition: 0.73; 95% CI, 0.66-0.81) and Precision Medicine in Cardiomyopathy score (before LGE addition: 0.68; 95% CI, 0.49-0.77; after LGE addition: 0.73; 95% CI, 0.64-0.82) SCD predictive models. Conclusions and relevance: In this retrospective cohort study, quantitative LGE was a risk factor for SCD in patients younger than 21 years with HCM and improved risk stratification.

Accuracy of Pediatric Interventricular Septal Thickness Measurement Obtained Via Point-of-Care Ultrasound

Electromechanical Relationship in Hypertrophic Cardiomyopathy

Test Characteristics of Cardiac Point-of-Care Ultrasound in Children With Preexisting Cardiac Conditions

Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease

Accuracy of Point‐Of‐Care Cardiac Ultrasound Performed on Patients Admitted to a Pediatric Intensive Care Unit in Shock

Abstract 14817: Machine Learning Computer Vision for Point of Care Decision Support of Echocardiographic Identification of Hypertrophic Cardiomyopathy

Pilot Study Analyzing Automated ECG Screening of Hypertrophic Cardiomyopathy

Inaccuracy of Doppler Echocardiography Diagnoses Mild Congenital Heart Disease Related Pulmonary Hypertension

Abstract 12668: Prevalence of Phenotypic Hypertrophic Cardiomyopathy Among Students Referred for Sport Pre-Participation Cardiovascular Screening

Cardiac point of care ultrasound in resource limited settings to manage children with congenital and acquired heart disease

Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management

Reliability of Doppler-based Measurement of Pulmonary Vascular Resistance in Congenital Heart Disease with Non-restrictive Defect

Severe Mitral Regurgitation Diagnosis Through Point-of-Care Ultrasound During Initial Physical Examination

Multimodal Assessment and Intramodal Comparison of Imaging Techniques for Pediatric Pulmonary Vein Stenosis with Pulmonary Hypertension

Accuracy of point‐of‐care ultrasound in the diagnosis of acute appendicitis in a pediatric emergency department

Dual-source Computed Tomography for Evaluating Pulmonary Artery and Aorta in Pediatric Patients with Single Ventricle.

Diagnostic accuracy of point-of-care ultrasound (PoCUS) for the diagnosis of hip effusion in the pediatric emergency department

Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study

Correlation of Transthoracic Echocardiographic Estimates of Right Ventricular Pressure with Right Ventricular Pressure Measurements on Cardiac Catheterization in Children with Pulmonary Hypertension

Focused Cardiac Ultrasound Diagnosis of Dilated Cardiomyopathy

Cardiac and lung point‐of‐care ultrasound in pediatric anesthesia and critical care medicine: Uses, pitfalls, and future directions to optimize pediatric care